Literature DB >> 10875316

Interleukin-16 in synovial fluids from cases of various types of arthritis.

Y Kageyama1, T Ozeki, M Suzuki, T Ichikawa, T Miura, S Miyamoto, A Machida, A Nagano.   

Abstract

OBJECTIVES: To examine the characteristic relationship between interleukin-16 (IL-16) and clinical data in various types of arthritis.
METHODS: We measured IL-16 levels of the synovial fluids (SF) of patients with various types of arthritis, which included rheumatoid arthritis, traumatic arthritis, pseudogouty arthritis, gouty arthritis, and osteoarthritis, by an enzyme immunosorbent assay, and examined their correlations with clinical parameters. RESULTS AND
CONCLUSIONS: Higher levels of IL-16 in synovial fluid from patients with rheumatoid arthritis, traumatic arthritis, and pseudogouty arthritis, compared to those with osteoarthritis, and gouty arthritis were indicated. Also, synovial IL-16 levels in patients with rheumatoid arthritis correlated significantly, especially with synovial matrix metalloproteinase-3 levels. But the IL-16 levels of both synovial fluid and peripheral blood did not correlate with conventional inflammatory parameters such as C-reactive protein, erythrocyte sedimentation rate, or rheumatoid factor. Although the function of IL-16 in inflammatory arthritis has not yet been defined, these data indicated some essential features of IL-16.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10875316

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  3 in total

1.  Treatment with anti-TNF-alpha antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis.

Authors:  Yasunori Kageyama; Masaaki Takahashi; Eiji Torikai; Motohiro Suzuki; Tetsuya Ichikawa; Tetsuyuki Nagafusa; Yukio Koide; Akira Nagano
Journal:  Clin Rheumatol       Date:  2006-05-06       Impact factor: 2.980

2.  Repetitive Exposure of IL-17 Into the Murine Air Pouch Favors the Recruitment of Inflammatory Monocytes and the Release of IL-16 and TREM-1 in the Inflammatory Fluids.

Authors:  Francesco Maione; Asif Jilani Iqbal; Federica Raucci; Michal Letek; Martina Bauer; Fulvio D'Acquisto
Journal:  Front Immunol       Date:  2018-11-30       Impact factor: 7.561

3.  Genomic risk prediction of aromatase inhibitor-related arthralgia in patients with breast cancer using a novel machine-learning algorithm.

Authors:  Raquel E Reinbolt; Stephen Sonis; Cynthia D Timmers; Juan Luis Fernández-Martínez; Ana Cernea; Enrique J de Andrés-Galiana; Sepehr Hashemi; Karin Miller; Robert Pilarski; Maryam B Lustberg
Journal:  Cancer Med       Date:  2017-11-23       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.